Efficacy, Safety, and Net Clinical Benefit of Post‐Atrial Fibrillation Ablation Anticoagulation
This meta-analysis suggests that after successful AF ablation, continuing OAC does not significantly reduce stroke risk compared to cessation or switching to aspirin, but it may increase major bleeding. While NCB trends favor cessation, the low absolute event rates and the risk of silent AF recurrence necessitate caution.
Authors
- Rana Rashwan (ORCID: https://orcid.org/0000-0001-9557-0062)
- Azad Mojahedi
- Mohamed Elnady (ORCID: https://orcid.org/0000-0002-8921-7622)
- Mahmoud M. Shams (ORCID: https://orcid.org/0009-0009-1227-714X)
- Ahmed Mohamed (ORCID: https://orcid.org/0009-0000-1186-2595)
- Moshe Gunsburg
- Imad Samman Tahhan (ORCID: https://orcid.org/0009-0004-3778-1565)
- Zeyad Kholeif
- A E Elalfy
- Mustafa Abomohsen
- Ahmed Farid Gadelmawla
- Abdul Hakim Almakadma
- Mohab Elnashar
Institutions
- Lincoln Medical Center (US)
- Brigham and Women's Hospital (US)
- New York City Health and Hospitals Corporation (US)
- Kafrelsheikh University (EG)
- Harvard University (US)
- Wellington City Council (NZ)
- Jacksonville College (US)
- Brookdale University Hospital and Medical Center (US)
- Digestive CARE (US)
- Northeast Baptist Hospital (US)
- Mayo Clinic in Florida (US)
- Menoufia University (EG)
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- Pacing and Clinical Electrophysiology
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1111/pace.70224
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00